You can read Jo Churchill's latest speeches and appearances in Parliament below:
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period.
Enzyme replacement therapy for CLN2 (Batten disease) is available through a managed access agreement.
The Department does not identify essential health products for policy purposes.
The Department along with NHS England and NHS Improvement and Public Health England (PHE) are currently planning for the delivery of a su
The 2019 Voluntary Scheme for Branded Medicines Pricing and Access set out a range of measures to support innovation and improve patient
The NHS Business Services Authority is unable to provide the number of National Health Service prescription items for unlicensed cannabis
The European Commission formally issued the marketing authorisation for Kaftrio on 21 August.
Departmental Ministers and officials regularly discuss a range of matters with colleagues in the National Institute for Health and Care E